Concepedia

Douglas K. Miller

DK

Statistics

Publications

18

Citations

9K

H-Index

17

Active since

1985

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Canada Inc. (Canada)

Brigham and Women's Hospital

Douglas K. Miller is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and immunology.

Publications per year

1985–2009

18

Publications

18

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

Donald W. Nicholson, Ambereen Ali, Nancy A. Thornberry et al. · Nature · 1995 · 4K citations

, , +13

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. · Nature · 1992 · 2.6K citations

, , +12

CPP32/Apopain Is a Key Interleukin 1β Converting Enzyme-like Protease Involved in Fas-mediated Apoptosis

Jörg Schlegel, Iris Peters, Sten Orrenius et al. · Journal of Biological Chemistry · 1996 · 476 citations · Full text

, , +17

The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation

Ting-Ting Yamin, Douglas K. Miller · Journal of Biological Chemistry · 1997 · 282 citations · Full text

, , +12

Molecular Cloning and Pro-apoptotic Activity of ICErelII and ICErelIII, Members of the ICE/CED-3 Family of Cysteine Proteases

Neil A. Munday, John P. Vaillancourt, Ambereen Ali et al. · Journal of Biological Chemistry · 1995 · 281 citations · Full text

, , +14

1–5 of 18